Phase I Trial of Phenformin With Dabrafenib and Trametinib in Patients With BRAFV600E/K-mutated Melanoma
Phase of Trial: Phase I
Latest Information Update: 22 Aug 2018
At a glance
- Drugs Dabrafenib (Primary) ; Phenformin (Primary) ; Trametinib (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 13 Aug 2018 Planned End Date changed from 1 Jan 2019 to 1 Jan 2020.
- 13 Aug 2018 Planned primary completion date changed from 1 Jan 2019 to 1 Jan 2020.
- 01 Feb 2017 New trial record